Global and United States Chemical Medication in COVID-19 Market Report & Forecast 2022-2028

According to China's clinical trials of COVID-19 treatment, the most clinically tested varieties are chemical drugs, especially chloroquine and antiviral drugs. Due to effective control, the proportion of clinical trials in China has been greatly reduced. Among the chemical drug clinical projects, chloroquine accounted for the largest proportion, followed by ritonavir、lopinavir and ridacive.
This report focuses on the investigation and analysis of chemical medication in COVID-19 and predicts the future market development of biopharmaceuticals under the influence of COVID-19.
Market Analysis and Insights: Global and United States Chemical Medication in COVID-19 Market
This report focuses on global and United States Chemical Medication in COVID-19 market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Chemical Medication in COVID-19 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Remedsivir accounting for % of the Chemical Medication in COVID-19 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, COVID-19 was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Chemical Medication in COVID-19 market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Chemical Medication in COVID-19 Scope and Market Size
Chemical Medication in COVID-19 market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chemical Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Chemical Medication in COVID-19 market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Remedsivir
Ardidol
Favipivir
Lopinavir/ritonavir (LPV/r)
Chloroquine
Others
Segment by Application
COVID-19
Influenza
Malaria
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Gilead Sciences
AbbVie
Johnson & Johnson
Pfizer
Mylan
Bayer
Zhejiang Hisun
CSPC Pharmaceutical Group
Reyoung Pharmaceutical
Sihuan Pharmaceutical
Hikma Pharmaceuticals
Rising Pharmaceutical
Sun Pharma
Shanghai Pharma
Guangzhou Baiyunshan Guanghua Pharmaceutical
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group

Frequently Asked Questions